Newron Pharmaceuticals S.p.A.
Newron Pharmaceuticals S.p.A. (NWPHF) Stock Overview
Explore Newron Pharmaceuticals S.p.A.’s financial performance, market position, analyst ratings, and future outlook.
Key Financials
Key Financials
Market Cap
239.5M
P/E Ratio
8.00
EPS (TTM)
N/A
ROE
16.69%
NWPHF Stock Analysis & Investment Overview
Our comprehensive AI-powered analysis of Newron Pharmaceuticals S.p.A. (NWPHF) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.
Our forecasting models predict significant price movements, with a 12-month target of N/A.
Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 8.00 and a market capitalization of 239.5M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.